FDA · Drug recall
ManukaGuard Medical Grade Manuka Honey Allercleanse Nasal Spray…
- Date
- March 3, 2021
- Risk class
- Class I (FDA's definition, 21 CFR 7.3(m): a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death)
- Status
- Ongoing
- Filed by
- NDAL Mfg Inc.
- Product
- ManukaGuard Medical Grade Manuka Honey Allercleanse Nasal Spray, 1.3 FL OZ (40mL) bottle, 270 measured sprays, Distributed by Ndal Laboratories, 449 Alvarado St., Monterey, CA 93940 (bottle); NDAL MFG Inc., 80 Garden Court, Suite 100, Monterey, CA 93940 (carton); UPC 8 58631 00212 8. the Alvarado St. is for the bottle by putting "(bottle); NDAL MFG Inc., 80 Garden Court, Suite 100, Monterey, CA 93940 (carton); UPC 8 58631 00212 8." (according to the label)
- Reason
- Microbial Contamination of Non-Sterile Products: Product confirmed to have yeast
- Distribution pattern
- Distributed Nationwide in the USA and Hong Kong
- Quantity
- 4265 bottles
- Codes and lots
- LOT # 2010045; Best Before 10 2023
- Recall started
- Dec. 17, 2020
- Recall number
- D-0269-2021
What should I do? Medicine recall: what to do
Source: FDA · Drug enforcement report, recall number D-0269-2021. The agency record governs; check it and the company before acting.